Ftse Mib
38.421,05
0,45%
DAX
22.287,56
-0,24%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
-2,20%
Bitcoin
95.444,66
-0,86%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Akari Therapeutics PLC (AKTX) Akari Therapeutics PLC (AKTX) Notizie

Akari Therapeutics PLC

AKTX
0,97
-0,085 (-8,06%)
21 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/2/202515:00GLOBEAkari Therapeutics Participates in the Virtual Investor “Top..
14/2/202523:00EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
03/2/202514:00GLOBEAkari Therapeutics Joins Webull Corporate Connect Service..
13/1/202514:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202514:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202514:00EDGAR2Form 8-K - Current report
10/1/202523:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/12/202422:30EDGAR2Form 8-K - Current report
18/12/202414:51GLOBEAkari Therapeutics Announces Key Leadership Appointments
16/12/202422:30EDGAR2Form 8-K - Current report
16/12/202415:05GLOBEAkari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief..
06/12/202422:00EDGAR2Form SC 13D/A - General Statement of Acquisition of..
03/12/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/11/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/11/202422:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/11/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:05EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/11/202422:27EDGAR2Form 8-K - Current report
08/11/202414:00EDGAR2Form 8-K - Current report
01/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/10/202414:51EDGAR2Form 425 - Prospectuses and communications, business..
11/10/202422:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/10/202422:27EDGAR2Form S-4/A - Registration of securities, business..
04/10/202422:30EDGAR2Form 8-K - Current report
03/10/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202412:43EDGAR2Form S-4/A - Registration of securities, business..
18/9/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/9/202422:34EDGAR2Form 8-K - Current report
16/9/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/9/202423:30EDGAR2Form S-4 - Registration of securities, business combinations
06/9/202423:23EDGAR2Form S-3 - Registration statement under Securities Act of..
23/8/202422:30EDGAR2Form 8-K/A - Current report: [Amend]
19/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/8/202422:15EDGAR2Form 8-K - Current report
15/8/202422:15EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
20/6/202413:30EDGAR2Form SC 13D/A - General statement of acquisition of..
18/6/202422:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
08/6/202400:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
Apertura: 1,03 Min: 0,95 Max: 1,045
Chiusura: 1,055

La tua Cronologia

NASDAQ
AKTX
Akari Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci